165 related articles for article (PubMed ID: 33655684)
41. Prenatal diagnosis of cerebral and extracerebral high-flow lesions revealing familial capillary malformation-arteriovenous malformation (CM-AVM) syndrome.
Lacalm A; Fichez A; Broussin B; Abel C; Lacombe D; Guibaud L
Ultrasound Obstet Gynecol; 2018 Mar; 51(3):409-411. PubMed ID: 28295764
[No Abstract] [Full Text] [Related]
42. Outcome with topical sirolimus for port wine stain malformations after unsatisfactory results with pulse dye laser treatment alone.
Musalem HM; Alshaikh AA; Tuleimat LM; Alajlan S
Ann Saudi Med; 2018; 38(5):376-380. PubMed ID: 30284993
[TBL] [Abstract][Full Text] [Related]
43. Capillary malformation-arteriovenous malformation syndrome: identification of a family with a novel mutation.
Boyden LM; Orme CM; Antaya RJ; Choate KA; King BA
J Am Acad Dermatol; 2012 Dec; 67(6):e287-9. PubMed ID: 23158644
[No Abstract] [Full Text] [Related]
44. Port wine stain treated with a combination of pulsed dye laser and topical rapamycin ointment.
Griffin TD; Foshee JP; Finney R; Saedi N
Lasers Surg Med; 2016 Feb; 48(2):193-6. PubMed ID: 26503090
[TBL] [Abstract][Full Text] [Related]
45. [Potential and limitations of dye laser therapy for capillary malformations].
Klein A; Hohenleutner U
HNO; 2014 Jan; 62(1):25-9. PubMed ID: 24357234
[TBL] [Abstract][Full Text] [Related]
46. Rhodoid naevus syndrome: why is this name preferable to 'capillary malformation-arteriovenous malformation'?
Panzer R; Happle R; Fölster-Holst R
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):e446-e448. PubMed ID: 28401589
[No Abstract] [Full Text] [Related]
47. Observations on enhanced port wine stain blanching induced by combined pulsed dye laser and rapamycin administration.
Nelson JS; Jia W; Phung TL; Mihm MC
Lasers Surg Med; 2011 Dec; 43(10):939-42. PubMed ID: 22127673
[No Abstract] [Full Text] [Related]
48. Vascular Stains: Proposal for a Clinical Classification to Improve Diagnosis and Management.
Rozas-Muñoz E; Frieden IJ; Roé E; Puig L; Baselga E
Pediatr Dermatol; 2016 Nov; 33(6):570-584. PubMed ID: 27456075
[TBL] [Abstract][Full Text] [Related]
49. De novo intracranial arteriovenous malformation development after endovascular treatment for a pial arteriovenous fistula in capillary malformation-arteriovenous malformation syndrome.
Ryu B; Sato S; Mochizuki T; Inoue T; Okada Y; Niimi Y
Interv Neuroradiol; 2021 Feb; 27(1):25-30. PubMed ID: 32635776
[TBL] [Abstract][Full Text] [Related]
50. Capillary malformation-arteriovenous malformation syndrome associated with basilar artery aneurysm.
Guimaraes MJ; Gomes J; Lopes G; Caldas R; Brito C
Pediatr Dermatol; 2022 Jul; 39(4):662-663. PubMed ID: 35503512
[TBL] [Abstract][Full Text] [Related]
51. Laser applications for benign oral lesions.
Frigerio A; Tan OT
Lasers Surg Med; 2015 Oct; 47(8):643-50. PubMed ID: 26308664
[TBL] [Abstract][Full Text] [Related]
52. 5q14.3 Microdeletions: A Contiguous Gene Syndrome with Capillary Malformation-Arteriovenous Malformation Syndrome and Neurologic Findings.
Park SM; Kim JM; Kim GW; Kim HS; Kim BS; Kim MB; Ko HC
Pediatr Dermatol; 2017 Mar; 34(2):156-159. PubMed ID: 28297145
[TBL] [Abstract][Full Text] [Related]
53. Unilateral segmental presentation and a novel EPHB4 gene variant in capillary malformation-arteriovenous malformation type 2.
Valente C; Caldeira MB; Duarte B; Batista J; Cordeiro AI
Pediatr Dermatol; 2024; 41(2):344-345. PubMed ID: 38092051
[TBL] [Abstract][Full Text] [Related]
54. Retrospective study of photodynamic therapy for pulsed dye laser-resistant port-wine stains.
Han Y; Ying H; Zhang X; Yu W; Cen Q; Chen X; Qiu Y; Chen H; Jin Y; Ma G; Lin X
J Dermatol; 2020 Apr; 47(4):348-355. PubMed ID: 32012364
[TBL] [Abstract][Full Text] [Related]
55. Central nervous system screening in capillary malformation-arteriovenous malformation syndrome: An observational study.
Boccara O; Mazereeuw J; Martin L; Bessis D; Hubiche T; Chiaverini C; Dompmartin A; Mallet S; Miquel J; Aubert H; Puzenat E; Abasq C; Gusdorf L; Hadj-Rabia S; Maruani A; ;
J Am Acad Dermatol; 2022 Oct; 87(4):914-916. PubMed ID: 34954287
[No Abstract] [Full Text] [Related]
56. A case of capillary malformation-arteriovenous malformation and Ebstein's anomaly in a child with EphB4 mutation.
Sherwani Y; Jenkins S; Adelanwa A; Burch DM; Chaudhuri NR; Zinn Z
Pediatr Dermatol; 2021 Sep; 38(5):1305-1307. PubMed ID: 34339071
[TBL] [Abstract][Full Text] [Related]
57. Macrocheilia as an Atypical Clinical Presentation of Capillary Malformation-Arteriovenous Malformation Type 2.
Rovira-López R; Pérez-Jurado LA; Pujol RM
JAMA Dermatol; 2024 Apr; 160(4):474-476. PubMed ID: 38353959
[TBL] [Abstract][Full Text] [Related]
58. Long-pulsed 1,064-nm high-energy dye laser improves resistant port wine stains: 20 report cases.
Liu S; Yang C; Yang S
Lasers Med Sci; 2012 Nov; 27(6):1225-7. PubMed ID: 22552924
[No Abstract] [Full Text] [Related]
59. [Therapeutic indications for percutaneous laser in patients with vascular malformations and tumors].
Labau D; Cadic P; Ouroussoff G; Ligeron C; Laroche JP; Guillot B; Dereure O; Quéré I; Galanaud JP
J Mal Vasc; 2014 Dec; 39(6):363-72. PubMed ID: 25086985
[TBL] [Abstract][Full Text] [Related]
60. Successful management of an arteriovenous malformation with trametinib in a patient with capillary-malformation arteriovenous malformation syndrome and cardiac compromise.
Nicholson CL; Flanagan S; Murati M; Boull C; McGough E; Ameduri R; Weigel B; Maguiness S
Pediatr Dermatol; 2022 Mar; 39(2):316-319. PubMed ID: 35014097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
